These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11243504)

  • 1. The pharmacologic profile of desloratadine: a review.
    Henz BM
    Allergy; 2001; 56 Suppl 65():7-13. PubMed ID: 11243504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desloratadine: A new, nonsedating, oral antihistamine.
    Geha RS; Meltzer EO
    J Allergy Clin Immunol; 2001 Apr; 107(4):751-62. PubMed ID: 11295678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.
    Banfield C; Gupta S; Marino M; Lim J; Affrime M
    Clin Pharmacokinet; 2002; 41(4):311-8. PubMed ID: 11978146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of clinically relevant interaction between desloratadine and erythromycin.
    Banfield C; Hunt T; Reyderman L; Statkevich P; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():29-35. PubMed ID: 12169044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug.
    Agrawal DK
    Expert Opin Investig Drugs; 2001 Mar; 10(3):547-60. PubMed ID: 11424898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desloratadine has no clinically relevant electrocardiographic or pharmacodynamic interactions with ketoconazole.
    Banfield C; Herron J; Keung A; Padhi D; Affrime M
    Clin Pharmacokinet; 2002; 41 Suppl 1():37-44. PubMed ID: 12169045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desloratadine: an update of its efficacy in the management of allergic disorders.
    Murdoch D; Goa KL; Keam SJ
    Drugs; 2003; 63(19):2051-77. PubMed ID: 12962522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desloratadine.
    McClellan K; Jarvis B
    Drugs; 2001; 61(6):789-96; discussion 797. PubMed ID: 11398910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy.
    DuBuske L
    Am J Clin Dermatol; 2007; 8(5):271-83. PubMed ID: 17902729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and safety profile of rupatadine when coadministered with azithromycin at steady-state levels: a randomized, open-label, two-way, crossover, Phase I study.
    Solans A; Izquierdo I; Donado E; Antonijoan R; Peña J; Nadal T; Carbó ML; Merlos M; Barbanoj M
    Clin Ther; 2008 Sep; 30(9):1639-50. PubMed ID: 18840369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis.
    Bachert C
    Allergy; 2001; 56 Suppl 65():14-20. PubMed ID: 11243500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and safety profile of desloratadine and fexofenadine when coadministered with azithromycin: a randomized, placebo-controlled, parallel-group study.
    Gupta S; Banfield C; Kantesaria B; Marino M; Clement R; Affrime M; Batra V
    Clin Ther; 2001 Mar; 23(3):451-66. PubMed ID: 11318079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desloratadine: A preclinical and clinical overview.
    Norman P; Dihlmann A; Rabasseda X
    Drugs Today (Barc); 2001 Apr; 37(4):215-227. PubMed ID: 12768222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desloratadine activity in concurrent seasonal allergic rhinitis and asthma.
    Baena-Cagnani CE
    Allergy; 2001; 56 Suppl 65():21-7. PubMed ID: 11243501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics, electrocardiographic effects, and tolerability of loratadine syrup in children aged 2 to 5 years.
    Salmun LM; Herron JM; Banfield C; Padhi D; Lorber R; Affrime MB
    Clin Ther; 2000 May; 22(5):613-21. PubMed ID: 10868558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Desloratadine in the treatment of chronic idiopathic urticaria.
    Ring J; Hein R; Gauger A
    Allergy; 2001; 56 Suppl 65():28-32. PubMed ID: 11243502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic profile of desloratadine in healthy adults, including elderly.
    Affrime M; Gupta S; Banfield C; Cohen A
    Clin Pharmacokinet; 2002; 41 Suppl 1():13-9. PubMed ID: 12169042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 2nd communication: lack of central nervous system and cardiovascular effects.
    Kreutner W; Hey JA; Chiu P; Barnett A
    Arzneimittelforschung; 2000 May; 50(5):441-8. PubMed ID: 10858871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of desloratadine on the control of morning symptoms in patients with seasonal and perennial allergic rhinitis.
    Schenkel EJ
    Allergy Asthma Proc; 2006; 27(6):465-72. PubMed ID: 17176780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.